Vontobel Holding’s Perspective Therapeutics CATX Stock Holding History

Vontobel Holding’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$60.2K	Hold	22,000	–	–	﹤0.01%	1455
2026 Q2	$74.9K	Buy	22,000 +4,000	+22%	+$15.1K	﹤0.01%	1427
2026 Q1	$75.1K	Sell	18,000 -7,000	-28%	-$29.6K	﹤0.01%	1164
2025 Q4	$68.6K	Buy	25,000 +5,000	+25%	+$14.3K	﹤0.01%	1389
2025 Q3	$69K	Hold	20,000	–	–	﹤0.01%	1311
2025 Q2	$68.8K	Hold	20,000	–	–	﹤0.01%	1220
2025 Q1	$42.6K	Buy	20,000 +4,000	+25%	+$12K	﹤0.01%	1066
2024 Q4	$51K	Buy	+16,000	New	+$131K	﹤0.01%	1070
2024 Q2	–	Sell	-8,000	Closed	-$95.2K	–	1088
2024 Q1	$95.2K	Buy	+8,000	New	+$68.2K	﹤0.01%	1029

Other funds holding CATX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Nicholson Wealth Management Group Charlestown, South Carolina $168M AUM 6.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Hills Bank & Trust North Liberty, Iowa $2.37B AUM 11.39% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return

WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Vontobel Holding's CATX Position: Q3 2026 in Review

Vontobel Holding held its Perspective Therapeutics (CATX) position steady in Q3 2026 at 22,000 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

Vontobel Holding first reported a position in CATX in Q1 2024 and has held it in 9 quarters since. The position peaked at $95.2K in Q1 2024. 55 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

Vontobel Holding held 22,000 shares of Perspective Therapeutics worth $60.2K as of Q3 2026.
Vontobel Holding left its Perspective Therapeutics share count unchanged in Q3 2026.
Perspective Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1455 holding.
Vontobel Holding first reported a position in Perspective Therapeutics in Q1 2024 and has held it in 9 quarters since.
Vontobel Holding's Perspective Therapeutics position peaked at $95.2K in Q1 2024.
55 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.